Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leprosy in Guatemala 1982].

F A Cordero

    Acta Leprologica
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Leprosy, historically known as "Lazarus illness," remains endemic in Guatemala. The Institute of Dermatology (INDERMA) has provided extensive care and identified the north-east zone as the primary endemic area.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Venereal granuloma. Its clinical manifestation in the genitals and other parts of the body].

    Medicina cutanea ibero-latino-americana·1975
    Same author

    [Leishmaniasis americana. Report on the development of a case, with rare mucocutaneous lesions].

    Archivos del Colegio Medico de El Salvador·1965
    Same author

    [USE OF LAURYL SULFATE OF THE PROPIONIC ESTER OF ERYTHROMYCIN IN THE ORAL TREATMENT OF EARLY SYPHILIS AND OF CHANCROID].

    Revista del Colegio Medico de Guatemala·1963
    Same author

    Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid.

    Antibiotics & chemotherapy (Northfield, Ill.)·1961
    Same author

    [Vitiligo. Contribution to its etiopathogenic study and its treatment].

    Revista del Colegio Medico de Guatemala·1961
    Same author

    American leishmaniasis; report of a case with unusual mucocutaneous lesions.

    Archives of dermatology and syphilology·1950

    Area of Science:

    • Dermatology
    • Epidemiology
    • Public Health

    Background:

    • Leprosy has been present in Guatemala since 1527, historically referred to as "Lazarus illness."
    • Leprosy patients were historically treated in various institutions, including "The Mercy Hospital" (1530), "The Saint Lazarus Hospital" (1638), "The Piety Asylum" (1874), and "The Ramiro Galvez Leprosarium" (1972).
    • The "Guatemala Leprosy Patronage" and the Institute of Dermatology (INDERMA) were established in 1973.

    Purpose of the Study:

    • To provide a historical overview of leprosy in Guatemala from 1527 to 1982.
    • To detail the services and patient statistics provided by INDERMA from 1973 to 1982.
    • To identify the endemic areas and characteristics of leprosy patients in Guatemala.

    Main Methods:

    • Review of historical records of leprosy treatment facilities and patient care.

    Related Experiment Videos

  • Analysis of patient data from INDERMA's hospital and outpatient clinics (1973-1982).
  • Clinical examination of individuals through INDERMA's rural anti-leprosy campaign.

    • Main Results:

    • INDERMA provided 101,206 health services between 1973 and 1982, including treatment for 79,241 skin disease patients and 3,685 new/existing leprosy cases.
    • The rural campaign identified 137 new leprosy cases among 12,096 examined healthy individuals, confirming the north-east zone as the endemic area.
    • As of January 1982, Guatemala had 410 verified leprosy cases, predominantly lepromatous type (49.04%), with males (62.43%) and the 30-39 age group (19.24%) most affected. The endemic zone showed a prevalence index of 0.345%.

    Conclusions:

    • INDERMA's efforts have been crucial in managing leprosy in Guatemala, with a focus on the endemic north-east region.
    • The study highlights the epidemiological characteristics of leprosy in Guatemala, including predominant types and demographic distribution.
    • Ongoing study and care of leprosy patients continue across Guatemala as the endemic area is controlled.